Research on improving kindergarten yards for children's health

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of rewilding kindergarten yards on children's health by enhancing biodiversity. It aims to evaluate how these changes affect the commensal microbiome, prevalence of allergies, asthma, atopic dermatitis, and cognitive skills in children aged 1-5. The study will involve 320 participants, with assessments of microbiota diversity, health symptoms, cortisol levels, and cognitive abilities. The approach includes both observational and microbiological analyses to understand the health benefits of increased biodiversity in urban settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Attendance in kindergarten

Exclusion Criteria:

* Use of antibiotics in the year before sampling

Where it's running

• Natural Resources Institute Finland
  Helsinki, Uusimaa, Finland Recruiting
• Tampere University
  Tampere, Finland Recruiting

Study contacts

• Principal investigator: Aki Sinkkonen — Natural Resources Institute Finland
• Study coordinator: Sanna Hurtola
• Email: sanna.hurtola@luke.fi
• Phone: +358295322500

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Exploring how playing in sand affects atopic dermatitis in children

  This study is testing if playing in sand can help young children with eczema feel better by looking at their skin and immune system changes.

  Recruiting at 2 sites Natural Resources Institute Finland · Helsinki, Uusimaa and 1 other locations · NCT06390696

• Roflumilast Cream 0.3% for moderate to severe atopic dermatitis in children, adolescents, and adults

  A cream called roflumilast 0.3% is tested once daily to see if it helps people with moderate to severe atopic dermatitis, compared to a non-medicated cream, across ages 6 and up.

  Recruiting at 4 sites Phase 3 Arcutis Biotherapeutics, Inc. · Birmingham, Alabama and 3 other locations · NCT07916480

• Nocturnal ScratchSense ring: test of automatic scratch detection in adults with itchy skin

  This study tests whether the Replior ScratchSense ring can accurately detect and measure nighttime scratching in adults with itchy skin conditions.

  Recruiting Replior AB · Grenoble · NCT07909967

• What the Mayo Clinic is learning from blood clot tests in allergic reactions

  This study tests whether real-time blood clotting markers can help understand and predict the severity of allergic reactions and anaphylaxis in patients 12 and older.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07905911

• ADBest TREAT Registry for adults with atopic dermatitis

  A registry in Germany is collecting real-world data from adults with atopic dermatitis to see how treatments are used and how the disease affects quality of life.

  Recruiting Universitätsklinikum Hamburg-Eppendorf · Hamburg · NCT07904546

• N-WATCH: Can a simple breath device help monitor asthma in kids

  This study tests the N-Tidal C device to see if it helps monitor asthma in children aged 5 to under 16 who have wheeze or asthma and are not critically ill.

  Recruiting at 2 sites University of Nottingham · Nottingham, Nottinghamshire and 1 other locations · NCT07833826

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.